ID Nutra’s satiety product gets EFSA novel food nod

7e527e52-7d94-4731-945f-194ae0257fcaarticleimage.jpg

28 Sep 2017 --- The thirst and hunger suppressing specimen H. parviflora, marketed by ID Nutra as SatiPlus, has been approved as a novel food by the European Food Safety Authority (EFSA). The product’s potential benefits include a host of advantages related to weight loss and metabolism.

“The SatiPlus powder’s function as appetite suppressant, traditionally used as such in Africa, makes it ideal to consumers who want convenience,” Karin Nielsen, Vice President of ID Nutra SL, tells NutritionInsight. “They can achieve convenient ways to curb the hunger they typically struggle with when trying to lose weight.”

“Since 2015, when this whole food ingredient of H. parviflora was accepted in Ireland, it has been under scrutiny in the EFSA novel food workgroup. It has been a long journey due to structural changes at EFSA, but finally we’re here,” says Iris Danieli, CEO of Desert Labs Inc., the company behind H. parviflora for which ID Nutra is the commercial partner in the EU.

Effective suppressor of thirst and hunger
“As we all know, there are no miracle cures or quick fixes for losing weight. Reducing caloric intake, increasing energy turnover – and, in extreme cases, surgical assistance – are the only recognized ways to reduce the waistline,” Nielsen notes.

Since the 1930s, the thirst- and hunger-suppressing properties of Hoodia plants from Africa have been recognized and studied, ID Nutra notes.

Both authorities and the industry work hard to improve consumer diets in terms of caloric intake, mainly via reducing fat and sugar content. However, calories from snacking represent more than 25 percent of daily calorie intake for many consumers, according to ID Nutra.

The company adds that people who want to lose weight struggle with this daily habit, as well as issues with reversing their metabolic problems. These include rising blood glucose levels due to increased insulin resistance, hyperlipidemia and the risk of liver damage.

Desert Labs has evaluated the safety of its H. parviflora product with: a battery of published pre-clinical toxicological studies; a published, large clinical marketing study; and seven years in the commercial markets of the US (as well as several years in Russia and other countries) with no reports of adverse effects.

For example, data showed reduction of weight, BMI and waistline in a test group who had ice cubes with H. parviflora in their drinks daily, as opposed to the control group who did not have H. parviflora in their ice cubes.

Additionally, interesting results related to metabolic syndrome in a 30-day study of people with insulin resistance and non-alcoholic fatty liver disease demonstrated efficacy and no evidence of adverse events.

ID Nutra has branded the concept SatiPlus as it comprises both satiety and metabolic effects. “We expect to assist formulators in implementing SatiPlus in many innovative ‘anti-snacking’ solutions for consumers, such as capsules, tablets, soft drinks, fortified sweeteners, nutrition bars, lozenges, gummies and chewing gums,“ says Nielsen.

“The successes from the US and Asia, as well as the convenient dosage of this active botanical, leave opportunities for building a diverse usage,” Nielsen adds.

The natural powder from the H. parviflora has shown remarkable results, Nielsen says: “A single-blind, placebo-controlled 40-day study comprising 204 individuals consumed a supplementation of H. parviflora in flavored 3g ice cubes or placebo cubes. A statistically significant loss of BMI, weight and waistline was observed and self-reports were positive from the participants completing the study.”

ID Nutra notes that the ingredient is 100 percent natural and a whole-food – aligning perfectly with natural and clean label trends.

Looking to the future, Nielsen says ID Nutra is interested in operating in a business network of similar industry experts who have deep local insights. “You can say that we have a disruptive business model, aiming to expand across Europe, via partnerships, not via growing large organizations,” Nielsen says.

“At the moment, we’re open to more commercial partners in various regions, as well as application-specific companies who see an interest in innovating unique product concepts for the European markets,” Nielsen adds.

Desert Labs, together with ID Nutra, will now work with interested parties and introduce solutions at Vitafoods Europe 2018.

To contact our editorial team please email us at editorial@cnsmedia.com

ID Nutra S.L.

Collapse

ID Nutra is a company specialised in supplying nutraceuticals and nutritional ingredients for the health and wellness industry.  Our aim is to become the preferred supplier of nutraceutical and nutritional ingredients for the industry. We want to offer innovative solutions as well as service our clients with trends and market insights.

Our suppliers

Our suppliers are leading companies in the sector. They have developed innovative products, they have good control of their raw material supply chain, and offer the industry response to the trends in health and any formulation challenges they may meet. Currently, we have suppliers in Europe, America and Asia.

Mission and values

Our mission is to support the product development of our clients and to deliver ingredients that offer safe and innovative solutions to the market. The satisfaction of our clients is our purpose and our priority.

A qualified team

ID Nutra represents a team of qualified professionals with extensive experience in the sector. They strive to offer the right solution in every situation.

Related Articles

Health & Nutrition News

Mushrooms hold potential for prebiotic diabetes treatment, study finds

17 Aug 2018 --- Eating white button mushrooms can create subtle shifts in the microbial community in the gut, which could improve the regulation of glucose in the liver, according to a team of Penn State College of Agricultural Sciences researchers. They also suggest that better understanding this connection between mushrooms and gut microbes in mice could one day pave the way for new diabetes treatments and prevention strategies for people.

Health & Nutrition News

Low-carb diets could shorten life by four years, warns Lancet study

17 Aug 2018 --- Following a low-carb diet could shorten life expectancy by four years, suggests new research published in The Lancet Public Health. The high levels of animal fats and proteins that often replace carbohydrates in typical low-carb diets appear to be associated with the higher risk of mortality. Eating more plant-based proteins and fats in place of carbohydrates was linked to lower mortality and even reversed the greater mortality risk. 

Health & Nutrition News

Weekly Roundup: US consumers rank clean water as top health desire, high protein diet reduces risk of diabetes for those with fatty liver

17 Aug 2018 --- The weekly roundup is NutritionInsight's collection of global nutrition stories from the past week. A Nestlé Waters commissioned survey found that clean water is the most important health factor to US consumers and a study found that increasing the amount of protein in the diet may reduce the risk of diabetes in people with Non-Alcoholic Fatty Liver Disease (NAFLD). Australia based Freedom Foods acquired protein product brand Crankt to strengthen its position in the sports nutrition market. The European Commission (EC) approved an application from DSM Europe to rename the carotenoid zeaxanthin in the novel food register. CBI and Campden BRI are teaming up for a Colombian product development workshop and, lastly, the Council for Responsible Nutrition (CRN) announced eleven new additions to its membership ranks.

Health & Nutrition News

Molecular switch may serve as new target point for obesity and diabetes therapies, says study

16 Aug 2018 --- A mechanism of the PI3KC2A kinase enzyme may have significance for the future development of therapies against cancer, obesity and diabetes, research published in Molecular Cell has found. The study highlights how if specific signaling cascades are misregulated, diseases and metabolic disorders may occur. The identified mechanism may have a crucial influence on such signaling cascades.

Health & Nutrition News

ADM strengthens gut health strategy with US$235m Probiotics International acquisition

16 Aug 2018 --- Adding to a list of microbiome strategy investments, Archer Daniels Midland Company (ADM) has completed its acquisition of Probiotics International Limited (PIL) – known under its umbrella brand Protexin – in a US$235 million deal.

More Articles
URL : http://www.nutritioninsight.com:80/news/id-nutras-satiety-product-gets-efsa-novel-food-nod.html